Skip to main content
FinSpry Logo
FinSpry
RPRX logo
RPRX
(NASDAQ)
Royalty Pharma plc
$61.31-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Royalty Pharma (RPRX) Stock Price & Financial Analysis

Royalty Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$60.37 - $61.60
52-Week High$60.44
52-Week Low$34.08
Open$60.53
Volume2.33M
Average Volume (3M)2.79M
Market Cap34.31B
Shares Outstanding559.61M
P/E Ratio (TTM)40.20
Forward P/E53.10
Price to Sales (P/S)13.63
Price to Book (P/B)4.83
EV/EBITDA25.21
Revenue (TTM)2.44B
Net Income (TTM)827.60M
Free Cash Flow (TTM)2.20B
EPS (TTM)$1.48
Profit Margin33.91%
Operating Margin67.93%
Return on Equity (ROE)12.01%
Debt to Equity1.30
50-Day MA$56.91
200-Day MA$47.61
52-Week Change63.55%
Annual Dividend$0.93
Dividend Yield1.56%
Payout Ratio62.52%
Last Dividend Ex-DateAug 14, 2026

Frequently Asked Questions About Royalty Pharma

What is the current stock price for RPRX?

As of the latest trading session, RPRX stock trades at $61.31. The 52-week range is $34.08–$60.44, with a day range of $60.37–$61.60.

What is the P/E ratio for RPRX?

Royalty Pharma's trailing P/E ratio is 40.2, meaning investors pay $40.2 for every $1 of annual earnings. The forward P/E is 53.1, reflecting analyst expectations for future earnings. Royalty Pharma operates in the Healthcare sector.

Does RPRX pay dividends?

Yes, Royalty Pharma pays a 1.56% annual dividend yield ($0.93 per share). The payout ratio is 62.5%. The last ex-dividend date was 2026-08-14.

What do analysts recommend for RPRX?

Based on 3 analysts, the consensus for RPRX is Buy.

What is the market cap of RPRX?

Royalty Pharma's market capitalization is $34.31B, classifying it as a large-cap company. Royalty Pharma operates in the Healthcare sector within the Biotechnology industry.